Callinice CAPO-CHICHI

Dr. Callinice CAPO-CHICHI


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2011 in Chinese Journal of Cancer
Verified
Journal Article
Open access
CCCallinice CAPO-CHICHI
Callinice CAPO-CHICHI
KCKathy Q. Cai
Kathy Q. Cai
JSJennifer Smedberg
Jennifer Smedberg
PGParvin Ganjei-Azar
Parvin Ganjei-Azar
AGAndrew K. Godwin
Andrew K. Godwin
XXXiang-Xi Xu
Xiang-Xi Xu
Through advances in technology, the genetic basis of cancer has been investigated at the genomic level, and many fundamental questions have begun to be addressed. Among several key unresolved questions in cancer biology, the molecular basis for the link between nuclear deformation and malignancy has not been determined. Another hallmark of human cancer is aneuploidy; however, the causes and consequences of aneuploidy are unanswered and are hotly contested topics. We found that nuclear lamina proteins lamin A/C are absent in a significant fraction (38%) of human breast cancer tissues. Even in lamin A/C-positive breast cancer, lamin A/C expression is heterogeneous or aberrant (such as non-nuclear distribution) in the population of tumor cells, as determined by immunohistology and immunofluorescence microscopy. In most breast cancer cell lines, a significant fraction of the lamin A/C-negative population was observed. To determine the consequences of the loss of lamin A/C, we suppressed their expression by shRNA in non-cancerous primary breast epithelial cells. Down-regulation of lamin A/C in breast epithelial cells led to morphological deformation, resembling that of cancer cells, as observed by immunofluorescence microscopy. The lamin A/C-suppressed breast epithelial cells developed aneuploidy as determined by both flow cytometry and fluorescence in situ hybridization. We conclude that the loss of nuclear envelope structural proteins lamin A/C in breast cancer underlies the two hallmarks of cancer aberrations in nuclear morphology and aneuploidy.

26 March 2011 in BMC Medicine
Verified
Journal Article
Open access
PDF file
CCCallinice CAPO-CHICHI
Callinice CAPO-CHICHI
KCKathy Q Cai
Kathy Q Cai
FSFiona Simpkins
Fiona Simpkins
PGParvin Ganjei-Azar
Parvin Ganjei-Azar
AGAndrew K Godwin
Andrew K Godwin
XXXiang-Xi Xu
Xiang-Xi Xu
Background: Despite our substantial understanding of molecular mechanisms and gene mutations involved in cancer, the technical approaches for diagnosis and prognosis of cancer are limited. In routine clinical diagnosis of cancer, the procedure is very basic: nuclear morphology is used as a common assessment of the degree of malignancy, and hence acts as a prognostic and predictive indicator of the disease. Furthermore, though the atypical nuclear morphology of cancer cells is believed to be a consequence of oncogenic signaling, the molecular basis remains unclear. Another common characteristic of human cancer is aneuploidy, but the causes and its role in carcinogenesis are not well established. Methods: We investigated the expression of the nuclear envelope proteins lamin A/C in ovarian cancer by immunohistochemistry and studied the consequence of lamin A/C suppression using siRNA in primary human ovarian surface epithelial cells in culture. We used immunofluorescence microscopy to analyze nuclear morphology, flow cytometry to analyze cellular DNA content, and fluorescence in situ hybridization to examine cell ploidy of the lamin A/C-suppressed cells. Results: We found that nuclear lamina proteins lamin A/C are often absent (47%) in ovarian cancer cells and tissues. Even in lamin A/C-positive ovarian cancer, the expression is heterogeneous within the population of tumor cells. In most cancer cell lines, a significant fraction of the lamin A/C-negative population was observed to intermix with the lamin A/C-positive cells. Down regulation of lamin A/C in non-cancerous primary ovarian surface epithelial cells led to morphological deformation and development of aneuploidy. The aneuploid cells became growth retarded due to a p53-dependent induction of the cell cycle inhibitor p21. Conclusions: We conclude that the loss of nuclear envelope structural proteins, such as lamin A/C, may underlie two of the hallmarks of cancer - aberrations in nuclear morphology and aneuploidy.

1 October 2005 in Developmental Biology
Verified
Journal Article
Closed access
CCCallinice CAPO-CHICHI
Callinice CAPO-CHICHI
MRMalgorzata E. Rula
Malgorzata E. Rula
JSJennifer L. Smedberg
Jennifer L. Smedberg
LVLisa Vanderveer
Lisa Vanderveer
MPMichael S. Parmacek
Michael S. Parmacek
XXXiang-Xi Xu
Xiang-Xi Xu

24 September 2008 in Developmental Dynamics
Verified
Journal Article
Open access
PDF file
KCKathy Q. Cai
Kathy Q. Cai
CCCallinice CAPO-CHICHI
Callinice CAPO-CHICHI
MRMalgorzata E. Rula
Malgorzata E. Rula
DYDong‐Hua Yang
Dong‐Hua Yang
XXXiang-Xi Xu
Xiang-Xi Xu
The derivation of the primitive endoderm layer from the pluripotent cells of the inner cell mass is one of the earliest differentiation and morphogenic events in embryonic development. GATA4 and GATA6 are the key transcription factors in the formation of extraembryonic endoderms, but their specific contribution to the derivation of each endoderm lineage needs clarification. We further analyzed the dynamic expression and mutant phenotypes of GATA6 in early mouse embryos. GATA6 and GATA4 are both expressed in primitive endoderm cells initially. At embryonic day (E) 5.0, parietal endoderm cells continue to express both GATA4 and GATA6; however, visceral endoderm cells express GATA4 but exhibit a reduced expression of GATA6. By and after E5.5, visceral endoderm cells no longer express GATA6. We also found that GATA6 null embryos did not form a morphologically recognizable primitive endoderm layer, and subsequently failed to form visceral and parietal endoderms. Thus, the current study establishes that GATA6 is essential for the formation of primitive endoderm, at a much earlier stage then previously recognized, and expression of GATA6 discriminates parietal endoderm from visceral endoderm lineages. Developmental Dynamics 237:2820–2829, 2008.

10 April 2006 in Oncogene
Verified
Journal Article
Open access
PDF file
CCCorrado Caslini
Corrado Caslini
CCCallinice CAPO-CHICHI
Callinice CAPO-CHICHI
IRI H Roland
I H Roland
ENE Nicolas
E Nicolas
AYA T Yeung
A T Yeung
XXX-X Xu
X-X Xu
Altered expression of GATA factors was found and proposed as the underlying mechanism for dedifferentiation in ovarian carcinogenesis. In particular, GATA6 is lost or excluded from the nucleus in 85% of ovarian tumors and GATA4 expression is absent in majority of ovarian cancer cell lines. Here, we evaluated their DNA and histone epigenetic modifications in five ovarian epithelial and carcinoma cell lines (human ‘immortalized’ ovarian surface epithelium (HIO)-117, HIO-114, A2780, SKOV3 and ES2). GATA4 and GATA6 gene silencing was found to correlate with hypoacetylation of histones H3 and H4 and loss of histone H3/lysine K4 tri-methylation at their promoters in all lines. Conversely, histone H3/lysine K9 di-methylation and HP1γ association were not observed, excluding reorganization of GATA genes into heterochromatic structures. The histone deacetylase inhibitor trichostatin A, but not the DNA methylation inhibitor 5′-aza-2′-deoxycytidine, re-established the expression of GATA4 and/or GATA6 in A2780 and HIO-114 cells, correlating with increased histone H3 and H4 acetylation, histone H3 lysine K4 methylation and DNase I sensitivity at the promoters. Therefore, altered histone modification of the promoter loci is one mechanism responsible for the silencing of GATA transcription factors and the subsequent loss of a target gene, the tumor suppressor Disabled-2, in ovarian carcinogenesis.

11 June 2007 in Genesis
Verified
Journal Article
Closed access
PDF file
MRMalgorzata E. Rula
Malgorzata E. Rula
KCKathy Q. Cai
Kathy Q. Cai
RMRobert Moore
Robert Moore
DYDong‐Hua Yang
Dong‐Hua Yang
CSCory M. Staub
Cory M. Staub
XXXiang‐Xi Xu
Xiang‐Xi Xu